Patients with rheumatoid arthritis have increased CD56+ monocyte frequencies in the peripheral blood, where anti-TNF treatment reduces CD56+ monocyte frequency, and the reduction is associated with a better response (14). The gene discussed is NCAM1; the disease is rheumatoid arthritis.